Therefore, we concluded that treating cancer cells with METTL13 reinstates the G1/S checkpoint via the coordinated downregulation of CDK6, CDK4 and CCND1, which resulted in the decreased phosphorylation of Rb and consequently delayed cell cycle progression. This evidence concerns the gene CCND1 and cancer.